You just read:

AcelRx Pharmaceuticals Presents Phase 3 Results from ARX-04 Clinical Program at JAB Burn and Wound Care Symposium

News provided by

AcelRx Pharmaceuticals, Inc.

Feb 11, 2016, 07:00 ET